The Right to Return: Acknowledging Risks Taken by Health Workers
Health professionals who bravely combat Ebola abroad should have the assurance of returning home safely. Their sacrifices deserve recognition and support.
Health professionals who bravely combat Ebola abroad should have the assurance of returning home safely. Their sacrifices deserve recognition and support.
RevMed's cancer treatment appears inaccessible for certain patients, while the Supreme Court maintains an essential pathway for generic drugs amid ongoing biotech developments.
The pharmaceutical sector is witnessing a series of personnel changes, including new hires, departures, and promotions. Here’s a summary of the latest developments.
The belief in universal health care is strong, yet it raises questions about safety and accountability beyond mere access. Insights from practicing medicine overseas reveal these complexities.
Musicians, often idolized for their artistry, face personal challenges that are frequently overlooked. Ossama from Sultan + Shepard shares his own health battle, reminding us of their humanity.
In a notable shift, French courts are set to conduct 23 terrorism trials in 2026, with 18 of those involving women who participated in the Islamic State in Syria, reflecting evolving societal views.
As summer activities like kayaking on the Maquoketa River unfold, concerns about water pollution in Iowa raise health risks and disrupt outdoor enjoyment.
As we reflect on the six-year mark since the onset of the COVID-19 pandemic, experts are evaluating how coordinated responses to domestic violence have evolved during this challenging period.
The Department of Health and Human Services has announced that Americans at high risk of Ebola exposure during the ongoing outbreak in Central Africa will be able to receive an experimental antibody treatment.
A recent presentation on Revolution Medicines' pancreatic cancer drug garnered significant attention, earning a standing ovation. However, the broader biotech sector faced challenges this week.
In a recent late-stage trial, Otsuka's kidney drug Voyxact demonstrated a reduction in the decline of kidney function over one year, but the results did not meet anticipated outcomes.
The new EP 'Marynbow' from Manuel De Lorenzi and Paul Dc offers a compelling mix of drums, bass, and intricate textures, showcasing their collaborative synergy.
As RFK Jr. enters his second year as health secretary, he faces significant challenges, including staff vacancies and new regulations that intertwine politics with NIH operations.
This editorial examines the ongoing efforts by the Trump administration to dismantle diversity, equity, and inclusion initiatives and their potential effects on racial health disparities.
Recent findings have revealed a previously unknown location where HIV can remain hidden in the body, raising new questions for treatment strategies.
A plan for an Ebola quarantine center in Kenya that would only serve American personnel has drawn criticism from former US officials and health experts, who argue it deviates from established policy.
While Russian officials assert that German businesses are re-engaging with the St. Petersburg Economic Forum, the actual attendance may suggest otherwise, raising questions about the true level of involvement.
Despite not yet receiving approval, Revolution Medicines' pancreatic cancer drug is already the subject of discussions regarding its potential expanded applications.
As researchers work on developing treatments and vaccines for hantavirus, recent outbreaks highlight the urgency of their efforts amid limited funding.
Recent attacks by an Islamic State-linked militia in North Kivu have resulted in the deaths of 30 individuals and have disrupted the ongoing Ebola response, according to local officials.